nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PTGS2—head and neck cancer	0.84	1	CbGaD
Niflumic Acid—PLA2G1B—exocrine gland—head and neck cancer	0.00732	0.11	CbGeAlD
Niflumic Acid—CLCNKA—thyroid gland—head and neck cancer	0.00564	0.0849	CbGeAlD
Niflumic Acid—PLA2G1B—mouth—head and neck cancer	0.00548	0.0824	CbGeAlD
Niflumic Acid—CLCNKA—head—head and neck cancer	0.005	0.0753	CbGeAlD
Niflumic Acid—PLA2G1B—connective tissue—head and neck cancer	0.00336	0.0505	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—head and neck cancer	0.00328	0.719	CrCbGaD
Niflumic Acid—PLA2G1B—epithelium—head and neck cancer	0.00319	0.0479	CbGeAlD
Niflumic Acid—PTGS2—cartilage tissue—head and neck cancer	0.0031	0.0467	CbGeAlD
Niflumic Acid—SLC16A7—saliva-secreting gland—head and neck cancer	0.00308	0.0463	CbGeAlD
Niflumic Acid—SLC16A7—trachea—head and neck cancer	0.00237	0.0357	CbGeAlD
Niflumic Acid—PLA2G4A—saliva-secreting gland—head and neck cancer	0.00222	0.0335	CbGeAlD
Niflumic Acid—PLA2G4A—connective tissue—head and neck cancer	0.00204	0.0308	CbGeAlD
Niflumic Acid—PLA2G1B—head—head and neck cancer	0.00198	0.0298	CbGeAlD
Niflumic Acid—SLC16A7—thyroid gland—head and neck cancer	0.00188	0.0283	CbGeAlD
Niflumic Acid—PLA2G4A—trachea—head and neck cancer	0.00172	0.0258	CbGeAlD
Niflumic Acid—SLC16A1—epithelium—head and neck cancer	0.00171	0.0257	CbGeAlD
Niflumic Acid—SLC16A7—head—head and neck cancer	0.00167	0.0251	CbGeAlD
Niflumic Acid—PLA2G4A—thyroid gland—head and neck cancer	0.00136	0.0204	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS2—head and neck cancer	0.00128	0.281	CrCbGaD
Niflumic Acid—PTGS2—mouth—head and neck cancer	0.00126	0.0189	CbGeAlD
Niflumic Acid—SLC16A1—thyroid gland—head and neck cancer	0.0012	0.018	CbGeAlD
Niflumic Acid—SLC16A7—lymph node—head and neck cancer	0.00117	0.0176	CbGeAlD
Niflumic Acid—SLC16A1—head—head and neck cancer	0.00106	0.016	CbGeAlD
Niflumic Acid—PLA2G4A—lymph node—head and neck cancer	0.000843	0.0127	CbGeAlD
Niflumic Acid—PTGS1—connective tissue—head and neck cancer	0.000807	0.0121	CbGeAlD
Niflumic Acid—PTGS2—connective tissue—head and neck cancer	0.000772	0.0116	CbGeAlD
Niflumic Acid—PTGS1—epithelium—head and neck cancer	0.000766	0.0115	CbGeAlD
Niflumic Acid—SLC16A1—lymph node—head and neck cancer	0.000742	0.0112	CbGeAlD
Niflumic Acid—PTGS2—epithelium—head and neck cancer	0.000732	0.011	CbGeAlD
Niflumic Acid—PTGS1—trachea—head and neck cancer	0.000678	0.0102	CbGeAlD
Niflumic Acid—PTGS2—trachea—head and neck cancer	0.000648	0.00975	CbGeAlD
Niflumic Acid—PTGS2—lymphoid tissue—head and neck cancer	0.000564	0.00849	CbGeAlD
Niflumic Acid—PTGS1—thyroid gland—head and neck cancer	0.000536	0.00807	CbGeAlD
Niflumic Acid—PTGS1—head—head and neck cancer	0.000476	0.00716	CbGeAlD
Niflumic Acid—PTGS2—head—head and neck cancer	0.000455	0.00684	CbGeAlD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00042	0.00472	CbGpPWpGaD
Niflumic Acid—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000407	0.00457	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000406	0.00456	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000405	0.00455	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PLC beta mediated events—MAPK1—head and neck cancer	0.000402	0.00451	CbGpPWpGaD
Niflumic Acid—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—head and neck cancer	0.000396	0.00445	CbGpPWpGaD
Niflumic Acid—PLA2G4A—G-protein mediated events—MAPK1—head and neck cancer	0.000395	0.00443	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—head and neck cancer	0.000393	0.00442	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000391	0.0044	CbGpPWpGaD
Niflumic Acid—UGT1A9—PPARA activates gene expression—CYP1A1—head and neck cancer	0.000379	0.00426	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000373	0.0042	CbGpPWpGaD
Niflumic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.000371	0.00417	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—UROD—head and neck cancer	0.000362	0.00407	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGF Pathway—HRAS—head and neck cancer	0.000355	0.00399	CbGpPWpGaD
Niflumic Acid—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000346	0.00388	CbGpPWpGaD
Niflumic Acid—PTGS1—lymph node—head and neck cancer	0.000333	0.00501	CbGeAlD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK3—head and neck cancer	0.000325	0.00365	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—GSTM1—head and neck cancer	0.000321	0.00361	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000321	0.00361	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—STAT3—head and neck cancer	0.00032	0.00359	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—GSTM1—head and neck cancer	0.000319	0.00358	CbGpPWpGaD
Niflumic Acid—PTGS2—lymph node—head and neck cancer	0.000318	0.00479	CbGeAlD
Niflumic Acid—PLA2G4A—Endothelins—MAPK3—head and neck cancer	0.000317	0.00356	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000314	0.00353	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000311	0.00349	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK1—head and neck cancer	0.000309	0.00348	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000308	0.00347	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Phospholipid metabolism—PIK3CA—head and neck cancer	0.000307	0.00345	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—MAPK3—head and neck cancer	0.000305	0.00343	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Endothelins—MAPK1—head and neck cancer	0.000302	0.00339	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000296	0.00333	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—MAPK1—head and neck cancer	0.000291	0.00326	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—EGFR—head and neck cancer	0.00029	0.00326	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—UROD—head and neck cancer	0.000282	0.00316	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000281	0.00315	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—GSTM1—head and neck cancer	0.00028	0.00314	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000276	0.0031	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000273	0.00307	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00027	0.00304	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—head and neck cancer	0.000268	0.00302	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—CYP1A1—head and neck cancer	0.000265	0.00298	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000262	0.00294	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NAT2—head and neck cancer	0.000257	0.00289	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000256	0.00287	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000254	0.00286	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—head and neck cancer	0.000248	0.00279	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Opioid Signalling—MAPK1—head and neck cancer	0.000247	0.00277	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Endothelins—HRAS—head and neck cancer	0.000242	0.00272	CbGpPWpGaD
Niflumic Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—head and neck cancer	0.000234	0.00263	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—UROD—head and neck cancer	0.000233	0.00262	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000231	0.0026	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000228	0.00256	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—DPYD—head and neck cancer	0.000225	0.00253	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00022	0.00247	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—head and neck cancer	0.000219	0.00246	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000219	0.00246	CbGpPWpGaD
Niflumic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000217	0.00244	CbGpPWpGaD
Niflumic Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—head and neck cancer	0.000217	0.00244	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000216	0.00243	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000215	0.00241	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—PTEN—head and neck cancer	0.000214	0.00241	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—YAP1—head and neck cancer	0.000214	0.0024	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Endothelins—AKT1—head and neck cancer	0.000214	0.0024	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000208	0.00234	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000208	0.00234	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—AKT1—head and neck cancer	0.000206	0.00231	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Phospholipid metabolism—PTEN—head and neck cancer	0.000198	0.00223	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—KISS1—head and neck cancer	0.000195	0.00219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—STAT3—head and neck cancer	0.000192	0.00215	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—BCL2—head and neck cancer	0.000191	0.00214	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—UROD—head and neck cancer	0.00019	0.00214	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000184	0.00207	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—MAPK3—head and neck cancer	0.000183	0.00206	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000181	0.00203	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000175	0.00197	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—MAPK1—head and neck cancer	0.000174	0.00196	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000169	0.00189	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000167	0.00188	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CCND1—head and neck cancer	0.000164	0.00184	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000161	0.00181	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—GRP—head and neck cancer	0.00016	0.0018	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000158	0.00178	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000153	0.00172	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—head and neck cancer	0.000151	0.0017	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—UROD—head and neck cancer	0.000151	0.0017	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NAT2—head and neck cancer	0.00015	0.00169	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000148	0.00166	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000144	0.00162	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00014	0.00157	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—HRAS—head and neck cancer	0.00014	0.00157	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Phospholipid metabolism—PIK3CA—head and neck cancer	0.00014	0.00157	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000138	0.00155	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—DPYD—head and neck cancer	0.000132	0.00148	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.00013	0.00147	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—TYMS—head and neck cancer	0.000128	0.00144	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	0.000128	0.00144	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTM1—head and neck cancer	0.000127	0.00143	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—YAP1—head and neck cancer	0.000125	0.00141	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	0.000125	0.0014	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000124	0.0014	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000124	0.00139	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000124	0.00139	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000123	0.00138	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000123	0.00138	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GPX1—head and neck cancer	0.000122	0.00137	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP1A1—head and neck cancer	0.00012	0.00135	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000117	0.00132	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NAT2—head and neck cancer	0.000117	0.00131	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000116	0.0013	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000115	0.00129	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KISS1—head and neck cancer	0.000115	0.00129	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.00011	0.00124	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000108	0.00121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000104	0.00117	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	0.000103	0.00116	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000103	0.00116	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	0.000103	0.00116	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DPYD—head and neck cancer	0.000103	0.00115	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000102	0.00114	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.89e-05	0.00111	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	9.88e-05	0.00111	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	9.79e-05	0.0011	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	9.78e-05	0.0011	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—YAP1—head and neck cancer	9.73e-05	0.00109	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NAT2—head and neck cancer	9.69e-05	0.00109	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	9.59e-05	0.00108	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2—head and neck cancer	9.57e-05	0.00108	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GRP—head and neck cancer	9.47e-05	0.00106	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STAT6—head and neck cancer	9.19e-05	0.00103	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.8e-05	0.000989	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DPYD—head and neck cancer	8.5e-05	0.000955	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	8.48e-05	0.000953	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.39e-05	0.000943	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.31e-05	0.000933	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	8.22e-05	0.000923	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	8.19e-05	0.00092	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—YAP1—head and neck cancer	8.14e-05	0.000914	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—head and neck cancer	8.14e-05	0.000914	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—YAP1—head and neck cancer	8.06e-05	0.000906	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NAT2—head and neck cancer	7.9e-05	0.000888	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	7.83e-05	0.00088	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—MAPK3—head and neck cancer	7.7e-05	0.000865	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—TYMS—head and neck cancer	7.51e-05	0.000844	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2—head and neck cancer	7.44e-05	0.000836	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—head and neck cancer	7.43e-05	0.000834	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	7.4e-05	0.000831	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—MAPK1—head and neck cancer	7.32e-05	0.000823	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.31e-05	0.000822	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—head and neck cancer	7.16e-05	0.000804	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GPX1—head and neck cancer	7.11e-05	0.000799	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP1A1—head and neck cancer	7.04e-05	0.000791	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	7e-05	0.000786	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DPYD—head and neck cancer	6.93e-05	0.000778	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.66e-05	0.000748	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	6.66e-05	0.000748	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	6.66e-05	0.000748	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.59e-05	0.000741	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—YAP1—head and neck cancer	6.57e-05	0.000739	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.38e-05	0.000716	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—PIK3CA—head and neck cancer	6.35e-05	0.000714	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—head and neck cancer	6.33e-05	0.000711	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NAT2—head and neck cancer	6.27e-05	0.000705	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTEN—head and neck cancer	6.24e-05	0.000701	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—head and neck cancer	6.15e-05	0.000691	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.06e-05	0.000681	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—MAPK3—head and neck cancer	5.98e-05	0.000672	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HRAS—head and neck cancer	5.88e-05	0.00066	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TYMS—head and neck cancer	5.84e-05	0.000657	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	5.78e-05	0.000649	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—head and neck cancer	5.78e-05	0.000649	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—MAPK1—head and neck cancer	5.69e-05	0.00064	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	5.59e-05	0.000628	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GPX1—head and neck cancer	5.53e-05	0.000621	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DPYD—head and neck cancer	5.5e-05	0.000618	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP1A1—head and neck cancer	5.48e-05	0.000615	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.28e-05	0.000594	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—YAP1—head and neck cancer	5.22e-05	0.000586	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—AKT1—head and neck cancer	5.19e-05	0.000583	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PIK3CA—head and neck cancer	4.94e-05	0.000555	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.94e-05	0.000555	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TYMS—head and neck cancer	4.84e-05	0.000544	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—head and neck cancer	4.79e-05	0.000538	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—head and neck cancer	4.78e-05	0.000537	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.72e-05	0.00053	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPX1—head and neck cancer	4.58e-05	0.000515	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HRAS—head and neck cancer	4.57e-05	0.000514	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP1A1—head and neck cancer	4.54e-05	0.00051	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.5e-05	0.000505	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PIK3CA—head and neck cancer	4.4e-05	0.000495	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.31e-05	0.000484	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2—head and neck cancer	4.27e-05	0.00048	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—head and neck cancer	4.19e-05	0.00047	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—AKT1—head and neck cancer	4.04e-05	0.000454	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TYMS—head and neck cancer	3.95e-05	0.000443	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—head and neck cancer	3.9e-05	0.000438	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPX1—head and neck cancer	3.74e-05	0.00042	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.73e-05	0.000419	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP1A1—head and neck cancer	3.7e-05	0.000416	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH1—head and neck cancer	3.67e-05	0.000412	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTEN—head and neck cancer	3.65e-05	0.00041	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKT1—head and neck cancer	3.6e-05	0.000404	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—MAPK3—head and neck cancer	3.43e-05	0.000386	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.42e-05	0.000384	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—MAPK1—head and neck cancer	3.27e-05	0.000367	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EGFR—head and neck cancer	3.27e-05	0.000367	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—head and neck cancer	3.26e-05	0.000366	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TYMS—head and neck cancer	3.13e-05	0.000352	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—head and neck cancer	3.1e-05	0.000348	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.04e-05	0.000341	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPX1—head and neck cancer	2.97e-05	0.000333	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP1A1—head and neck cancer	2.94e-05	0.00033	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTEN—head and neck cancer	2.84e-05	0.000319	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3CA—head and neck cancer	2.84e-05	0.000319	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOTCH1—head and neck cancer	2.81e-05	0.000316	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—head and neck cancer	2.7e-05	0.000303	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HRAS—head and neck cancer	2.62e-05	0.000295	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3CA—head and neck cancer	2.58e-05	0.000289	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2—head and neck cancer	2.52e-05	0.000284	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCND1—head and neck cancer	2.46e-05	0.000276	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.41e-05	0.000271	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTEN—head and neck cancer	2.37e-05	0.000267	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTEN—head and neck cancer	2.35e-05	0.000264	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT1—head and neck cancer	2.32e-05	0.00026	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—head and neck cancer	2.2e-05	0.000247	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—head and neck cancer	2.14e-05	0.000241	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STAT3—head and neck cancer	2.12e-05	0.000239	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKT1—head and neck cancer	2.1e-05	0.000236	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAPK3—head and neck cancer	2.03e-05	0.000228	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3CA—head and neck cancer	2e-05	0.000225	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAPK1—head and neck cancer	1.93e-05	0.000217	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGFR—head and neck cancer	1.93e-05	0.000217	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTEN—head and neck cancer	1.92e-05	0.000216	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PTEN—head and neck cancer	1.82e-05	0.000204	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3CA—head and neck cancer	1.68e-05	0.000188	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3CA—head and neck cancer	1.66e-05	0.000187	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKT1—head and neck cancer	1.64e-05	0.000184	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—STAT3—head and neck cancer	1.63e-05	0.000183	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—head and neck cancer	1.62e-05	0.000182	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MAPK3—head and neck cancer	1.55e-05	0.000175	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HRAS—head and neck cancer	1.55e-05	0.000174	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTEN—head and neck cancer	1.52e-05	0.000171	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MAPK1—head and neck cancer	1.48e-05	0.000166	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGFR—head and neck cancer	1.48e-05	0.000166	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT1—head and neck cancer	1.37e-05	0.000154	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKT1—head and neck cancer	1.36e-05	0.000152	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.35e-05	0.000152	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PIK3CA—head and neck cancer	1.28e-05	0.000144	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HRAS—head and neck cancer	1.19e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKT1—head and neck cancer	1.11e-05	0.000124	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3CA—head and neck cancer	1.07e-05	0.000121	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT1—head and neck cancer	1.05e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKT1—head and neck cancer	8.78e-06	9.86e-05	CbGpPWpGaD
